Of the 16 HER2-neu-positive cases, 56.25% (n = 9) were distal tumours, 31.25% (n = 5) were proximal tumours, and 12.5% (n = 2) were in the body of the stomach. This evidence concerns the gene ERBB2 and neoplasm.